CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
2 research outputs found
Dupilumab reduces absenteeism in patients with moderate to severe atopic dermatitis: Pooled results from the LIBERTY AD SOLO clinical trials
Author
Bégo-Le Bagousse G.
Chen Z.
+7Â more
Cork M.
de Bruin-Weller M.
Eckert L.
Gadkari A.
Msihid J.
Simpson E.L.
Taniou C.
Publication venue
'Elsevier BV'
Publication date
03/06/2020
Field of study
Get PDF
Crossref
White Rose Research Online
PSS43 - DUPILUMAB IMPROVES ABSENTEEISM IN MODERATE-TO-SEVERE ATOPIC DERMATITIS PATIENTS COMPARED WITH PLACEBO IN PHASE 3 LIBERTY AD SOLO STUDIES
Author
A. Gadkari
A. Rossi
+8Â more
C. Taniou
G. Bégo-Le Bagousse
J. Msihid
L. Eckert
M. Ardeleanu
M. de Bruin-Weller
Q. Chen
Z. Chen
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref